Universal Biosensors, Inc. (ASX:UBI)

Revenue by Product

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Coagulation Testing Products	2.88M
Coagulation Testing Products Growth	10.42%
Wine Testing Products	2.41M
Wine Testing Products Growth	-4.69%
Laboratory Testing Services	885.41K
Laboratory Testing Services Growth	-11.13%
Veterinary Diabetes Products	108.25K
Veterinary Diabetes Products Growth	-78.36%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Other	914.66K
Other Growth	-54.42%
Americas	2.53M
Americas Growth	32.12%
Europe	2.53M
Europe Growth	10.13%
Australia	311.39K
Australia Growth	-93.54%
Other	914.66K
Other Growth	-54.42%